Requirements and Registration for Healthcare Associated Venous Thromboembolism Prevention Challenge; Amendment of Notice, 38185 [2016-13850]

Download as PDF Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–13847 Filed 6–10–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES organizations. Champions were recognized as HA–VTE Prevention Champions and will receive a cash award of $10,000. A maximum of $80,000 will now be awarded in this challenge, an increase of $10,000. Additional honorable mention awards were also made to deserving entries. Federal and international winners received non-monetary recognition but no prize. Authority: 15 U.S.C. 3719. Centers for Disease Control and Prevention (CDC) Dated: June 7, 2016. Sandra Cashman, Executive Secretary, Centers for Disease Control and Prevention. Requirements and Registration for Healthcare Associated Venous Thromboembolism Prevention Challenge; Amendment of Notice [FR Doc. 2016–13850 Filed 6–10–16; 8:45 am] BILLING CODE 4163–18–P Authority: 15 U.S.C. 3719. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AWARD APPROVING OFFICIAL: Thomas R. Frieden, MD, MPH, Director, Centers for Disease Control and Prevention, and Administrator, Agency for Toxic Substances and Disease Registry. ACTION: Notice. DEPARTMENT OF HEALTH AND HUMAN SERVICES The Centers for Disease Control and Prevention (CDC) located within the Department of Health and Human Services (HHS) announces an amendment to its notice entitled, Announcement of Requirements and Registration for Healthcare Associated Venous Thromboembolism Prevention Challenge. This amendment is being made to reflect an increase in the number of Champions and change the maximum total prize disbursement. There are no other changes to the September 22, 2015 notice. FOR FURTHER INFORMATION CONTACT: Michele Beckman, Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop E–64, Atlanta, GA 30329, Telephone: 404–498–6474, Fax: 404– 498–6799, Attention: HA–VTE Prevention Challenge, Email: havtechallenge@cdc.gov. SUPPLEMENTARY INFORMATION: Subject of Challenge Competition: On September 22, 2015 CDC announced the Requirements and Registration for Healthcare Associated Venous Thromboembolism Prevention Challenge (80 FR 57187). This notice announces an increase in the number of Champions, from 7 to 8. The Champions were selected from the highest scoring U.S. hospitals, multi-hospital systems, hospital networks, and managed care The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. AGENCY: srobinson on DSK5SPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 20:48 Jun 10, 2016 Jkt 238001 Centers for Disease Control and Prevention [30-Day–16–16CA] Agency Forms Undergoing Paperwork Reduction Act Review PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 38185 To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Update seat belt fit recommendation for children—New—National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Centers for Disease Control and Prevention (CDC) is seeking OMB approval to conduct a new information collection for a study entitled, ‘‘Update Seat Belt Fit Recommendation for Children,’’ over a period of three years. CDC seeks to measure how seat belts fit children in vehicles with and without booster seats. The scientific basis for the current height recommendation for when children can transition from using a booster seat to just a seat belt is from a 1993 study that is outdated (Durbin et al., 2011; Reed et al., 2013). The goal of the new collection is to use the latest technology among the largest sample of children to date to help inform when children can safely transition from using a booster seat with a seat belt to using only a seat belt. Findings from this data collection will inform CDC’s child passenger safety recommendation regarding when children can safely transition from using a booster seat with the seat belt to using only the seat belt. This study will also provide information on ways to further reduce motor vehicle-related injuries and deaths among children. Prospective study participants will be children aged 6–12 years old in the greater District of Columbia (DC) area. Parents of prospective study participants will answer a series of screening questions to determine eligibility. Children who meet the screening criteria and are willing to participate will complete an in-person measurement session. Data will be analyzed using descriptive statistics, mean, standard deviation, and logistic regression. Selected findings will eventually be published in a peerreviewed journal. The estimated annual burden hours are 466. There are no costs to respondents other than their time. E:\FR\FM\13JNN1.SGM 13JNN1

Agencies

[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Page 38185]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13850]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


Requirements and Registration for Healthcare Associated Venous 
Thromboembolism Prevention Challenge; Amendment of Notice

    Authority: 15 U.S.C. 3719.

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

AWARD APPROVING OFFICIAL:  Thomas R. Frieden, MD, MPH, Director, 
Centers for Disease Control and Prevention, and Administrator, Agency 
for Toxic Substances and Disease Registry.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) located 
within the Department of Health and Human Services (HHS) announces an 
amendment to its notice entitled, Announcement of Requirements and 
Registration for Healthcare Associated Venous Thromboembolism 
Prevention Challenge. This amendment is being made to reflect an 
increase in the number of Champions and change the maximum total prize 
disbursement. There are no other changes to the September 22, 2015 
notice.

FOR FURTHER INFORMATION CONTACT: Michele Beckman, Division of Blood 
Disorders, National Center on Birth Defects and Developmental 
Disabilities, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE., Mailstop E-64, Atlanta, GA 30329, Telephone: 404-498-6474, 
Fax: 404-498-6799, Attention: HA-VTE Prevention Challenge, Email: 
havtechallenge@cdc.gov.

SUPPLEMENTARY INFORMATION: 
    Subject of Challenge Competition: On September 22, 2015 CDC 
announced the Requirements and Registration for Healthcare Associated 
Venous Thromboembolism Prevention Challenge (80 FR 57187). This notice 
announces an increase in the number of Champions, from 7 to 8. The 
Champions were selected from the highest scoring U.S. hospitals, multi-
hospital systems, hospital networks, and managed care organizations. 
Champions were recognized as HA-VTE Prevention Champions and will 
receive a cash award of $10,000. A maximum of $80,000 will now be 
awarded in this challenge, an increase of $10,000. Additional honorable 
mention awards were also made to deserving entries. Federal and 
international winners received non-monetary recognition but no prize.

    Authority: 15 U.S.C. 3719.

    Dated: June 7, 2016.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2016-13850 Filed 6-10-16; 8:45 am]
BILLING CODE 4163-18-P